Hydroxymethylglutaryl-coenzyme A reductase (NADPH) kinase
RxNorm 67347
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 67347 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Hydroxymethylglutaryl-coenzyme A reductase (NADPH) kinase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
Hydroxymethylglutaryl-CoA reductase (NADPH) kinase
(Atom ID: 10804734)
SY
Synonym (SY):
Hydroxymethylglutaryl-coenzyme A reductase (NADPH) kinase
(Atom ID: 10804736)
SY
Synonym (SY):
Hydroxymethylglutaryl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate) kinase
(Atom ID: 10804738)
FN
Full form of descriptor (FN):
Hydroxymethylglutaryl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate) kinase (substance)
(Atom ID: 10804739)
SY